---
title: "NHS National Generic Pharmaceuticals Interim 2 2020"
ocid: "ocds-h6vhtk-028fa2"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028fa2"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-028fa2.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-028fa2.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)"
published: "2021-02-03"
---

# NHS National Generic Pharmaceuticals Interim 2 2020

Buyer: THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)  
Current stage: Award  
OCID: ocds-h6vhtk-028fa2

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028fa2)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-028fa2.json)

## Summary

The NHS Commissioning Board, operating under the name of NHS England, has completed a public procurement process titled "NHS National Generic Pharmaceuticals Interim 2 2020," centred in the UK. This tender falls within the goods category, specifically related to various medicinal products under the CPV classification of 33690000. The procurement method used was an open procedure, with the tender stage having concluded as of February 1, 2021, for the first lot covering hospital-only products, and on March 1, 2021, for the second lot concerning orals and non-parenterals. The contract's duration was set for 12 months, with options for extensions up to a maximum of 48 months at the authority's discretion.

This tender represents a significant opportunity for businesses in the pharmaceuticals and healthcare sectors, particularly those specialising in providing medicinal products. Numerous suppliers are already participating in this framework, including some larger organisations and SMEs, all of which have a track record of supply within the healthcare industry. Companies equipped to respond to complex procurement specifications and that can meet rigorous quality and delivery standards are well-positioned to flourish in this competitive environment.

## Notice

Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) - Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority's discretion) fora period or periods up to a total of 36months.

### Lot Information

Interim 2 2020 - Hospital only products - All regions 01/02/2021 to 31/01/2022

NHS National Generic Pharmaceuticals Interim 2 2020Offer reference number: CM/PHG/20/5619Period of framework agreement: 12 months with an option or options to extend (at theAuthority's discretion) for a period or periods up to a total of 36 months. The totalmaximum duration of the framework agreement to be no more than 48 monthsPotential periods of call-offs under the framework agreement:Hospital only products - All regions: 01/02/2021 to 31/01/2022Orals (plus non-parenterals) - All regions: 01/03/2021 to 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurementdocuments

Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months

Interim 2 2020 - Orals (+ non-parenterals)- All regions 01/03/2021 to 28/02/2022

NHS National Generic Pharmaceuticals Interim 2 2020Offer reference number: CM/PHG/20/5619Period of framework agreement: 12 months with an option or options to extend (at theAuthority's discretion) for a period or periods up to a total of 36 months. The totalmaximum duration of the framework agreement to be no more than 48 monthsOJEU Reference number: [insert OJEU Reference number]Potential periods of call-offs under the framework agreement:Hospital only products - All regions: 01/02/2021 to 31/01/2022Orals (plus non-parenterals) - All regions: 01/03/2021 to 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Options to extend for up to a further 12 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/002124-2021 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Feb 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 21 Dec 2020 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 51 |
| Supplier names | ABBVIE; ACCORD-UK; ALTAN PHARMA; AMAROX; ASPIRE PHARMA; AVENTIS PHARMA LTD T/A SANOFI; BAXTER HEALTHCARE; BRISTOL LABORATORIES; BROWN AND BURK; CIPLA (EU; CONSILIENT HEALTH; CRESCENT PHARMA; CST PHARMA; DRUGSRUS; ESSENTIAL-HEALTHCARE; FOCUS PHARMACEUTICALS; FRESENIUS KABI; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HEALTHCARE PHARMA; HFA HEALTHCARE PRODUCTS; KENT PHARMA; LABORATORIO REIG JOFRE; LEXON; MACLEODS PHARMA; MANX HEALTHCARE; MARTINDALE PHARMA; MEDAC PHARMA; MEDLEY PHARMA; MEDREICH; MERCURY PHARMACEUTICALS; MILPHARM LTD/AUROBINBDO; MORNINGSIDE PHARMAEUTICALS; MYLAN; NECESSITY SUPPLIES; PANPHARMA; PFIZER; QDEM PHARMACEUTICALS; RANBAXY; RIVOPHARM; SANDOZ; SCIECURE PHARMA; SELECTIVE SUPPLIES; SYRI LIMITED (T/A THAME LABORATORIES; TEVA; THORNTON AND ROSS; TILLOMED LABORATORIES; UPJOHN; WAYMADE; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33690000 - Various medicinal products

## Release History

- 3 Feb 2021 at 09:40 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/002124-2021

## Notice URLs

- https://ted.europa.eu/udl?uri=TED:NOTICE:417114-2020:TEXT:EN:HTML
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028fa2. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-028fa2.json.